Funding

Open calls for research funding, each checked against its official source.

Funding opportunities

64

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

Funder: National Institutes of Health · Opportunity type: Grant

Supports small studies of ethical, legal and social issues in human genetics and genomics. Suitable projects include focused conceptual or legal analyses, preliminary data collection and secondary analysis of existing da...

Opens
2025-01-17
Deadline
2026-10-16
Funding amount
Up to USD 50000 in direct costs per year
Call status
Closed
Last checked
2026-09-19

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports early-stage ideas with potential to advance population-based cancer prevention and control. Projects may develop new methods, models or interventions addressing cancer risk, screening, behaviour or healthcare de...

Opens
2025-01-16
Deadline
2026-10-16
Funding amount
Up to USD 275000 in direct costs over 2 years; maximum USD 200000 per year
Call status
Closed
Last checked
2026-09-19

Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports definitive hybrid trials that assess both the effectiveness of mental health interventions and strategies for implementing them in accessible care or community settings. Studies must also examine a mechanism und...

Opens
2025-01-14
Deadline
2026-10-15
Call status
Closed
Last checked
2026-09-19

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports early translational studies of candidate treatments for neurological or neuromuscular disorders, including drug activity, pharmacokinetics and efficacy in living models. Projects should establish evidence needed...

Opens
2025-01-19
Deadline
2026-10-20
Funding amount
Up to USD 750000 in direct costs over 3 years; maximum USD 499000 per year
Call status
Closed
Last checked
2026-09-19

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports development of screening methods or early treatments for serious conditions identified through newborn screening, including high-priority genetic disorders that could become screenable. Projects should establish...

Opens
2025-01-05
Deadline
2026-10-05
Call status
Closed
Last checked
2026-09-19

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health · Opportunity type: Grant

Supported broadly applicable computational, statistical and bioinformatics methods for human genomics, including new analytical tools and scalable research software. This call closed early on 4 September 2026.

Opens
2025-01-06
Funding amount
Less than USD 500000 in direct costs per year
Call status
Closed
Last checked
2026-09-19

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Funder: National Institutes of Health · Opportunity type: Grant

Supported exploratory computational genomics and data science methods, including analytical approaches and software useful across diseases and biological systems. This call closed early on 4 September 2026.

Opens
2025-01-16
Funding amount
Up to USD 275000 in direct costs over 2 years; maximum USD 200000 per year
Call status
Closed
Last checked
2026-09-19

Laboratories to Optimize Digital Health (R01 Clinical Trial Required)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports clinical trials and digital research platforms that refine evidence-based mental health interventions. Projects should improve their reach, quality, efficiency or effectiveness using established digital mental h...

Opens
2025-01-05
Deadline
2026-10-05
Call status
Closed
Last checked
2026-09-19

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Funder: National Institutes of Health · Opportunity type: Grant

Supports laboratory and patient-based research into mechanisms linking incretin medicines, including GLP-1-related treatments, to cancer risk. Projects should investigate cancer-relevant effects beyond short-term weight ...

Opens
2025-01-05
Deadline
2026-10-05
Call status
Closed
Last checked
2026-09-19